Kenvue vs Procter & Gamble
Kenvue (KVUE) and Procter & Gamble (PG) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $37.1B
- Last close
- $19.31
- 12 months
- +35.6%
- Market value
- $395B
- Last close
- $170.29
- 12 months
- +15.8%
At a glance
- By market value, Procter & Gamble ($394.7B) is about 11 times Kenvue ($37.1B).
- Over the last 12 months Kenvue's share price moved +35.6% and Procter & Gamble's +15.8%; against the S&P 500 that is +24.4 points and +5.2 points.
- In their last fiscal years Kenvue kept 9.7% of revenue as net income and Procter & Gamble 18.4%.
- In the last 90 days insiders reported 0 open-market purchases at Kenvue and 0 at Procter & Gamble; members of Congress disclosed 1 trade in Kenvue and 9 in Procter & Gamble.
- Next results: Kenvue Feb 15, 2027, Procter & Gamble Jan 20, 2027.
Share prices on one chart
Kenvue and Procter & Gamble, and up to three more you add, drawn on the same scale so you can see which moved more.
Up to five lines: the two companies plus three more, any US-listed stock OQRO covers, or the index funds SPY, QQQ, DIA and IWM.
- Kenvue (KVUE)+10.8%deepest fall −13.3%
- Procter & Gamble (PG)+9.7%deepest fall −6.6%
May 1, 2026 to Oct 30, 2026. Dashed line = the starting level of 100.
Every line starts at 100 on May 1, 2026, the first day all 2 traded in the period. A line at 120 means the shares are worth 20% more than on that day, a line at 90 means 10% less, so the lines show how much each moved, not which share costs more.
From May 1, 2026 to Oct 30, 2026: Kenvue +10.8%, Procter & Gamble +9.7%. Kenvue did best and Procter & Gamble did worst.
The deepest fall is the largest drop from a high to a later low inside the period: it shows how hard the ride was, even for a share that ended up. Here the smallest was Procter & Gamble's (−6.6%).
Daily closing prices, not adjusted for dividends. Past prices, not a forecast, and not advice.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Free cash flow
Bars are scaled to the larger of the two; a − marks a loss or a fall.
Share price
Last 30 days
Last 90 days
Last 12 months
12 months against the S&P 500
Bars are scaled to the larger of the two; a − marks a loss or a fall.
Disclosed activity
Insider purchases, 90 days
Insider sales, 90 days
Congress trades, 90 days
Funds adding, 180 days
Bars are scaled to the larger of the two; a − marks a loss or a fall.
Every figure
| Kenvue KVUENYSE · Personal Care Products | Procter & Gamble PGNYSE · Personal Care Products | |
|---|---|---|
| Size and profitability | ||
| Market value | $37.1B | $395B |
| Revenue, last fiscal year | $15.1B | $87B |
| Net income, last fiscal year | $1.47B | $16B |
| Net marginNet income as a share of revenue | 9.7% | 18.4% |
| Free cash flow | $1.72B | $15.1B |
| Net debtDebt minus cash; negative means more cash than debt | — | $23.6B |
| Market value ÷ net incomeShown only when net income is positive | 25.2× | 24.6× |
| Market value ÷ revenue | 2.5× | 4.5× |
| Share price | ||
| Last close | $19.31 | $170.29 |
| Last 30 days | +9.3% | +8.0% |
| Last 90 days | +0.4% | +19.1% |
| Last 12 months | +35.6% | +15.8% |
| 12 months against the S&P 500Percentage points above or below the index | +24.4 pts | +5.2 pts |
| From the 12-month high | −2.9% | −1.6% |
| Disclosed activity | ||
| Insider purchases, last 90 daysOpen-market purchases reported on Form 4 | 0 | 0 |
| Value of those purchases | — | — |
| Insider sales, last 90 days | 0 | 21 |
| Congress trades, last 90 days | 1 | 9 |
| Funds adding, last 180 days13F positions opened or increased | 8 | 52 |
| Funds cutting, last 180 days | 15 | 73 |
| Federal contract awards, last 90 days | 0 | 0 |
| Record since 2006 and calendar | ||
| Insider records, last 12 months | 282 | 259 |
| Open-market purchases by insiders since 2006 | 4 | 21 |
| Open-market sales by insiders since 2006 | 3 | 1,294 |
| Last open-market purchase by an insider | Dec 15, 2025 | Oct 26, 2012 |
| Next results | Feb 15, 2027 | Jan 20, 2027 |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Procter & Gamble against
Common questions
How is Kenvue different from Procter & Gamble?
Kenvue (KVUE) is in Personal Care Products on NYSE, with $15.1B of revenue in its last fiscal year and a net margin of 9.7%. Procter & Gamble (PG) is in Personal Care Products on NYSE, with $87B of revenue in its last fiscal year and a net margin of 18.4%. Both are in the same industry, so the gap is mostly one of size and profitability. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Kenvue and Procter & Gamble compare in size?
Procter & Gamble has the larger market value: Kenvue $37.1B and Procter & Gamble $395B, at the last close.
Whose share price rose more over the last 12 months, KVUE or PG?
Over the last 12 months Kenvue moved +35.6% and Procter & Gamble +15.8%. Past price moves say nothing about the future.
Which has had more insider buying, Kenvue or Procter & Gamble?
Since 2006, Procter & Gamble insiders reported 21 open-market purchases against 4 for Kenvue. These are counts of what was filed, not a view on either stock.
Do members of Congress trade KVUE or PG?
In the last 12 months, members of Congress disclosed 15 trades in Kenvue (KVUE) and 32 in Procter & Gamble (PG).
When did insiders last buy KVUE and PG?
Kenvue: Dec 15, 2025. Procter & Gamble: Oct 26, 2012.
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Kenvue pageProcter & Gamble pageRare insider trades this weekAll comparisons
https://oqro.io/compare/kvue-vs-pg


